Advertisement

Outcomes of New-Generation Drug-Eluting Stents in Women with Acute Myocardial Infarction

  • Subrata KarEmail author
Ischemic Heart Disease (D Mukherjee, Section Editor)
  • 16 Downloads
Part of the following topical collections:
  1. Topical Collection on Ischemic Heart Disease

Abstract

Purpose of Review

This review discusses the outcomes of percutaneous coronary intervention (PCI) in women who experience acute myocardial infarction (AMI) and are treated with drug-eluting stents (DES). The review also describes the role of the new-generation DES compared with the early generation.

Recent Findings

Recent literature shows that the new-generation DES can be effective in women who present with AMI.

Summary

Women with AMI may be undertreated and are underrepresented in studies of AMI. Recently, it has been shown that the newer generation DES are effective and beneficial in women with AMI, similar to men. As further generations of DES are created, the future appears promising for continued advancements in women’s cardiovascular health.

Keywords

Drug-eluting stent Women Females Acute coronary syndrome Percutaneous coronary intervention Myocardial infarction 

Notes

Compliance with Ethical Standards

Conflict of Interest

Subrata Kar declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Yu J, Mehran R, Grinfeld L, Xu K, Nikolsky E, Brodie BR, et al. Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv. 2015;85(3):359–68.  https://doi.org/10.1002/ccd.25630.CrossRefPubMedGoogle Scholar
  2. 2.
    Pancholy SB, Shantha GP, Patel T, Cheskin LJ. Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. JAMA Intern Med. 2014;174(11):1822–30.  https://doi.org/10.1001/jamainternmed.2014.4762.CrossRefPubMedGoogle Scholar
  3. 3.
    • Udell JA, Fonarow GC, Maddox TM, Cannon CP, Frank Peacock W, Laskey WK, et al. Sustained sex-based treatment differences in acute coronary syndrome care: insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry. Clin Cardiol. 2018;41(6):758–68.  https://doi.org/10.1002/clc.22938 Important recent study which provides the results of the sex-based difference in ACS treatment.CrossRefPubMedGoogle Scholar
  4. 4.
    •• Giustino G, Harari R, Baber U, Sartori S, Stone GW, Leon MB, et al. Long-term safety and efficacy of new-generation drug-eluting stents in women with acute myocardial infarction: from the Women in Innovation and Drug-Eluting Stents (WIN-DES) collaboration. JAMA Cardiol. 2017;2(8):855–62.  https://doi.org/10.1001/jamacardio.2017.1978 Very important recent study which provides the evidence of the efficacy of new-generation DES in women with AMI.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kerkmeijer LS, Claessen BE, Baber U, Sartori S, Chandrasekhar J, Stefanini GG, et al. Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: from the WIN-DES collaborative patient-level pooled analysis. Int J Cardiol. 2018;263:24–8.  https://doi.org/10.1016/j.ijcard.2018.04.047.CrossRefPubMedGoogle Scholar
  6. 6.
    Chandrasekhar J, Baber U, Sartori S, Stefanini GG, Sarin M, Vogel B, et al. Effect of increasing stent length on 3-year clinical outcomes in women undergoing percutaneous coronary intervention with new-generation drug-eluting stents: patient-level pooled analysis of randomized trials from the WIN-DES initiative. JACC Cardiovasc Interv. 2018;11(1):53–65.  https://doi.org/10.1016/j.jcin.2017.11.020.CrossRefPubMedGoogle Scholar
  7. 7.
    Srinivas VS, Garg S, Negassa A, Bang JY, Monrad ES. Persistent sex difference in hospital outcome following percutaneous coronary intervention: results from the New York State reporting system. J Invasive Cardiol. 2007;19(6):265–8.PubMedGoogle Scholar
  8. 8.
    Lichtman JH, Wang Y, Jones SB, Leifheit-Limson EC, Shaw LJ, Vaccarino V, et al. Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR((R)). Am Heart J. 2014;167(3):376–83.  https://doi.org/10.1016/j.ahj.2013.11.001.CrossRefPubMedGoogle Scholar
  9. 9.
    Chandrasekhar J, Baber U, Sartori S, Faggioni M, Aquino M, Kini A, et al. Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: results from the PROMETHEUS study. Catheter Cardiovasc Interv. 2017;89(4):629–37.  https://doi.org/10.1002/ccd.26606.CrossRefPubMedGoogle Scholar
  10. 10.
    Peterson ED, Lansky AJ, Kramer J, Anstrom K, Lanzilotta MJ, National Cardiovascular Network Clinical I. Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol. 2001;88(4):359–64.CrossRefGoogle Scholar
  11. 11.
    Kunadian V, Qiu W, Lagerqvist B, Johnston N, Sinclair H, Tan Y, et al. Gender differences in outcomes and predictors of all-cause mortality after percutaneous coronary intervention (data from United Kingdom and Sweden). Am J Cardiol. 2017;119(2):210–6.  https://doi.org/10.1016/j.amjcard.2016.09.052.CrossRefPubMedGoogle Scholar
  12. 12.
    Udell JA, Koh M, Qiu F, Austin PC, Wijeysundera HC, Bagai A et al. Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularization. J Am Heart Assoc. 2017;6(1).  https://doi.org/10.1161/JAHA.116.004319.
  13. 13.
    Khera S, Kolte D, Gupta T, Subramanian KS, Khanna N, Aronow WS, et al. Temporal trends and sex differences in revascularization and outcomes of ST-segment elevation myocardial infarction in younger adults in the United States. J Am Coll Cardiol. 2015;66(18):1961–72.  https://doi.org/10.1016/j.jacc.2015.08.865.CrossRefPubMedGoogle Scholar
  14. 14.
    Josiah A, Farshid A. Gender is not a predictor of mortality or major adverse cardiovascular events in patients undergoing percutaneous coronary intervention for acute coronary syndromes. Heart Lung Circ. 2018.  https://doi.org/10.1016/j.hlc.2018.03.020.
  15. 15.
    Giustino G, Baber U, Stefanini GG, Aquino M, Stone GW, Sartori S, et al. Impact of clinical presentation (stable angina pectoris vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on long-term outcomes in women undergoing percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2015;116(6):845–52.  https://doi.org/10.1016/j.amjcard.2015.06.010.CrossRefPubMedGoogle Scholar
  16. 16.
    Giustino G, Baber U, Aquino M, Sartori S, Stone GW, Leon MB, et al. Safety and efficacy of new-generation drug-eluting stents in women undergoing complex percutaneous coronary artery revascularization: from the WIN-DES collaborative patient-level pooled analysis. JACC Cardiovasc Interv. 2016;9(7):674–84.  https://doi.org/10.1016/j.jcin.2015.12.013.CrossRefPubMedGoogle Scholar
  17. 17.
    Giustino G, Mastoris I, Baber U, Sartori S, Stone GW, Leon MB, et al. Correlates and impact of coronary artery calcifications in women undergoing percutaneous coronary intervention with drug-eluting stents: from the Women in Innovation and Drug-Eluting Stents (WIN-DES) collaboration. JACC Cardiovasc Interv. 2016;9(18):1890–901.  https://doi.org/10.1016/j.jcin.2016.06.022.CrossRefPubMedGoogle Scholar
  18. 18.
    Giustino G, Baber U, Salianski O, Sartori S, Stone GW, Leon MB, et al. Safety and efficacy of new-generation drug-eluting stents in women at high risk for atherothrombosis: from the Women in Innovation and Drug-Eluting Stents collaborative patient-level pooled analysis. Circ Cardiovasc Interv. 2016;9(1):e002995.  https://doi.org/10.1161/CIRCINTERVENTIONS.115.002995.CrossRefPubMedGoogle Scholar
  19. 19.
    Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):2354–94.  https://doi.org/10.1161/CIR.0000000000000133.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Cardiovascular Medicine, Paul L. Foster School of MedicineTexas Tech University Health Sciences Center El PasoEl PasoUSA

Personalised recommendations